Page URL:

Offer all prospective parents genetic screening, says study

6 November 2017
Appeared in BioNews 925

Genetic testing for cystic fibrosis, fragile X syndrome and spinal muscular atrophy is recommended for all would-be parents by a study in Australia.

The research is based on data from the Victorian Clinical Genetics Services (VCGS) which began to offer genetic testing in 2012 for these common and severe disorders.

Researchers anaylsed screenings of 12,000 individuals, and discovered that about 5 percent of them - 610 - were carriers of these diseases. This rate is on par with the population risk for Down's syndrome, and supports the stance that people should be routinely tested for these conditions, they said. Of the carriers, 88 percent had no family history and had no reason to suspect they were carrying these genetic disorders.

'There is also a misconception that these types of disorders are only relevant where there is a family history of the condition...but most parents who have a child with one of these disorders have no family history,' said senior author Professor David Amor, who is at the VCGS and Murdoch Children's Research Institute.

Genetic screening is typically done before pregnancy, but can be done during the first 12 weeks of gestation. Couples who are carriers of cystic fibrosis or spinal muscular atrophy have a 25 percent chance of having a baby with that disorder. Women who are carriers of the fragile X syndrome have a 50 percent change of passing on that mutation.

'It's important that all carriers are given the option of genetic counselling so they can discuss the implications of their results with an expert,' said Dr Alison Archibald at the VCGS, and joint first study-author.

Professor Amor added: 'Some couples will decide that [carrier screening] is not for them…but we know from experience that a lot of couples want this type of information.'

The study was published in Genetics in Medicine.

20 May 2019 - by Ana Hallgarten 
The Progress Educational Trust's event 'Testing Times: How Should We Use Genomic Data in Assisted Reproduction' took place at Amnesty International in London on the 16 May 2019. The event aimed to give members of the audience an insight into current uses of genomic data in assisted reproduction and its possible future uses...
20 November 2017 - by Catherine Joynson 
The new 'reflex' method of antenatal screening for Down's, Edwards' and Patau's syndromes was described last week as a 'transformational advance'. It might be cheaper than other approaches, but it could come at the cost of informed choice for pregnant women and couples...
20 November 2017 - by Nina Chohan 
The New York fertility clinic Reproductive Medicine Associates is facing two lawsuits from couples whose children, conceived using donor eggs from the centre, have Fragile X syndrome...
18 September 2017 - by Professor Becki Bennett 
A public event held on 11 September 2017, Manchester by the Progress Educational Trust...
4 September 2017 - by Dr Rachel Huddart 
Current prenatal chromosome screening tests could miss rare chromosomal abnormalities and lead to inaccurate results...
8 February 2016 - by Antony Starza-Allen 
A woman is suing healthcare professionals in the USA for failing to detect that she was a carrier of cystic fibrosis...
25 November 2013 - by Dr Felicity Boardman 
I was struck by a recent article that pushed to free Down's syndrome from inappropriate, negative language - that of 'disease', of 'risk' and of 'defect'...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.